An investment company advised by Maxburg has acquired a majority stake in MLase. MLase is a leading supplier specializing in UV-light medical products, based in Germering, near Munich.
Since its establishment in 2007, MLase has excelled in the development and manufacturing of innovative, high-quality laser and light systems, working closely with a notable roster of medical blue-chip OEM customers. The excimer lasers made by MLase form an integral part of numerous OEM systems used in applications such as refractive eye surgery, angiology, and glaucoma treatment.
The investment companies advised by Maxburg have an emphasis on the German-speaking market and focus on long-term investments in profitable, medium-sized companies with the aim of achieving a lasting and sustainable increase in value.
EGO HUMRICH WYEN advised Maxburg as lead counsel in an integrated team, including KNPZ Rechtsanwälte, Hamburg, on IP and data protection issues, Pusch Wahlig, Frankfurt, on employment law and Kaltwasser, Munich, on medical device law issues.
Advisors EGO HUMRICH WYEN: Dr. Jan-Henning Wyen, Dr. Alexander Ego, Dr. Achim Spengler
Contact information:
Dr. Jan-Henning Wyen
EGO HUMRICH WYEN
Unterer Anger 19, 80331 München
+49 (0) 89-12 50 10 30